Analysis of Subset Chimerism for MRD-Detection and Pre-Emptive Treatment in AML

Allogeneic hematopoietic stem cell transplantation (alloHCT) represents the only potentially curative treatment in high-risk AML patients, but up to 40% of patients suffer from relapse after alloHCT. Treatment of overt relapse poses a major therapeutic challenge and long-term disease control is achi...

Descripció completa

Dades bibliogràfiques

Autors principals:	Julia-Annabell Georgi, Sebastian Stasik, Martin Bornhäuser, Uwe Platzbecker, Christian Thiede
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2022-02-01
Col·lecció:	Frontiers in Oncology
Matèries:	AML allogeneic cell transplantation relapse detection subset chimerism pre-emptive treatment
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fonc.2022.841608/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!